Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A study carried out by the research group led by Prof Zaccolo provides novel insight into how the heart reacts to the fight-or-flight response to stress

Nature Communications

Image by M Machado and S Pantano

 

Prof Zaccolo explains their research and its significance below:

The primordial fight-or-flight response is a physiological reaction to stress. Under stress, the hormones adrenaline and noradrenaline trigger the production of a small signalling molecule, cAMP, that acts inside the cell to activate the appropriate reaction to the stressful situation. We developed a method, based on the use of fluorescent light, which allows us to see cAMP inside living cells. We have applied this technique to study the reaction of the heart to stress and we discovered a surprising feature of cAMP signals. We found that when adrenaline instructs the cardiac cells to generate cAMP, a multitude of different cAMP signals are generated. Each of these cAMP signals has a different function and is confined to a minuscule space within the cell, only a few millionths of a millimetre in size. We also found that in disease conditions, for example in heart failure, these tiny signals are disrupted. 

We are very excited about our findings because they offer the opportunity to think about treatment of cardiac disease in a completely new perspective. Current drugs typically use a ‘blanket’ approach, their action occurs indiscriminately across the entire cell.  If we understand how the tiny cAMP signals are generated in the heart - and we have already some good hints - we can target them individually and be more precise in the therapeutic intervention, increasing efficacy while minimising side effects.

Their paper "FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility" was published in Nature Communications.

The research published in this article was funded by the British Heart Foundation and the Oxford BHF CRE.

Read the full article here.

 

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.